Voptica Introduces Inverted Meniscus IOL to Improve Peripheral Vision at ESCRS

Voptica SL has introduced what it is calling the first and only inverted meniscus intraocular lens (ArtIOLs) to improve peripheral vision, according to a company news release. Introduced at the 2021 ESCRS symposium in Amsterdam, ArtIOLs mimic the optics of the natural crystalline lens providing optimized field curvature and peripheral astigmatism leading to an improved peripheral vision.

"Current intraocular lenses are designed to optimize image quality at the eye's central retina, with not much attention to their off-axis performance," Pablo Artal, PhD, CEO and Co-founder of Voptica, said in a company news release. "IOLs are very thin in comparison with our natural lens. The reason is obvious, because we favor surgery through a small incision, but from the point of view of the optics in the periphery, the impact can be important since standard lenses provide a wrong field curvature and elevated astigmatism."

More than 1,000 ArtIOLs have been already implanted. The ESCRS satellite symposia panel includes ose Luis Güell, MD (Spain), Oliver Findl, MD (Austria), Inés Yago, MD (Spain), as well as Dr. Artal (Spain) himself.

In addition of the benefits for patients in the periphery, ArtIOLs are customizable EDOF lenses that can be combined to achieve good vision at all distances without compromises. The lens is currently available for physicians in the European market. Voptica aims to have FDA approval in the future. 

Reference:

P. Artal, J.M. Marin, H. S Ginis, C. Robles, E. Alcon, E.Angel Villegas, P. Prieto, P. Taña-Rivero; Less astigmatism and better contrast sensitivity in the periphery of pseudophakic patients implanted with a new intraocular lens. Invest. Ophthalmol. Vis. Sci. 2021;62(8):2012.